Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Loncastuximab in high-risk and heavily pretreated relapse... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Loncastuximab in high-risk and heavily pretreated relapsed / refractory diffuse large B-cell lymphoma: a real-world analysis from 21 US centers.
0
Authors
Viktoriya Zelikson
38 more
Viktoriya Zelikson
•
Mehdi Hamadani
36 more
•
Emily Ayers
Published
November 14, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Carolina Digital Repository (University of North Carolina at Chapel Hill)
Topics
Biology
Cancer Oncology
Medicine
Internal Medicine
Pathology And Forensic Medicine
Show all topics
DOI
10.17615/yw6h-qa53
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Carolina Digital Repository (University of North Carolina at Chapel Hill)
Topics
Biology
Cancer Oncology
Medicine
Internal Medicine
Pathology And Forensic Medicine
Show all topics
DOI
10.17615/yw6h-qa53
Other Formats
PDF
